Schrdinger, Inc. provides a physics-based software platform that enables the discovery of novel molecules for drug development and material applications. The company is headquartered in New York, New York.
| Revenue (TTM) | $255.87M |
| Gross Profit (TTM) | $142.61M |
| EBITDA | $-160.87M |
| Operating Margin | -19.70% |
| Return on Equity | -26.30% |
| Return on Assets | -13.50% |
| Revenue/Share (TTM) | $3.48 |
| Book Value | $4.94 |
| Price-to-Book | 2.42 |
| Price-to-Sales (TTM) | 3.58 |
| EV/Revenue | 2.318 |
| EV/EBITDA | -10.82 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -1.20% |
| Shares Outstanding | $64.66M |
| Float | $58.70M |
| % Insiders | 2.94% |
| % Institutions | 107.71% |
Volatility is currently contracting